Trial Profile
Impact of platelet reactivity on clopidogrel after Percutaneous coronary intervention (PCI) with 2nd generation drug eluting stent on late lumen loss
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Dec 2015
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- 26 Dec 2015 New trial record